Dai, H., Wu, Z., Jia, H., Tong, C., Guo, Y., Ti, D., . . . Han, W. (2020). Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia. Journal of hematology and oncology, 13(1), 30-10. https://doi.org/10.1186/s13045-020-00856-8
Chicago-Zitierstil (17. Ausg.)Dai, Hanren, et al. "Bispecific CAR-T Cells Targeting Both CD19 and CD22 for Therapy of Adults with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia." Journal of Hematology and Oncology 13, no. 1 (2020): 30-10. https://doi.org/10.1186/s13045-020-00856-8.
MLA-Zitierstil (9. Ausg.)Dai, Hanren, et al. "Bispecific CAR-T Cells Targeting Both CD19 and CD22 for Therapy of Adults with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia." Journal of Hematology and Oncology, vol. 13, no. 1, 2020, pp. 30-10, https://doi.org/10.1186/s13045-020-00856-8.